Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Xeris Biopharma Holdings, Inc. (XERS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.8500+0.1800 (+10.78%)
At close: 04:00PM EDT
1.8000 -0.05 (-2.70%)
After hours: 07:27PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close1.6700
Open1.6600
Bid1.7900 x 3100
Ask1.8700 x 4000
Day's Range1.6600 - 1.8700
52 Week Range1.2500 - 3.1700
Volume1,524,006
Avg. Volume1,697,498
Market Cap250.732M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for XERS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Xeris Biopharma Holdings, Inc.
    Analyst Report: Eli Lilly and CompanyEli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
    Rating
    Fair Value
    Economic Moat
    4 days agoMorningstar
View more
Advertisement
Advertisement